253
Views
14
CrossRef citations to date
0
Altmetric
Review

Recent advances in the combination delivery of drug for leukemia and other cancers

&
Pages 213-223 | Received 18 Nov 2019, Accepted 10 Jan 2020, Published online: 22 Jan 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jianfeng Zhou, Pu Wang, Deng-Guang Yu & Yuanjie Zhu. (2023) Biphasic drug release from electrospun structures. Expert Opinion on Drug Delivery 20:5, pages 621-640.
Read now

Articles from other publishers (13)

Xiaoshuai Liu, Shuai Wu, Huaying Wu, Tiange Zhang, Haifeng Qin, Yufeng Lin, Baojun Li, Xiqun Jiang & Xianchuang Zheng. (2023) Fully Active Delivery of Nanodrugs In Vivo via Remote Optical Manipulation. Small Methods.
Crossref
Kangjia Luo, Yanni Song, Zilong Guan, Suwen Ou, Jinhua Ye, Songlin Ran, Hufei Wang, Yangbao Tao, Zijian Gong, Tianyi Ma, Yinghu Jin, Rui Huang, Feng Gao & Shan Yu. (2022) A KRAS-Associated Signature for Prognostic, Immune and Chemical Anti-Cancer Drug-Response Prediction in Colon Cancer. Frontiers in Pharmacology 13.
Crossref
M. Konhäuser, V.K. Kannaujiya, E. Steiert, K. Schwickert, T. Schirmeister & P.R. Wich. (2022) Co-encapsulation of l-asparaginase and etoposide in dextran nanoparticles for synergistic effect in chronic myeloid leukemia cells. International Journal of Pharmaceutics 622, pages 121796.
Crossref
Weitong Xu, Tingting Zhao, Honghan Chen, Ning Huang, Hui Gong, Jian Zhang, Yu Yang, Tiepeng Li, Gongchang Zhang, Chuhui Gong, Ming Yang & Hengyi Xiao. (2022) Pan-mTOR inhibitors sensitize the senolytic activity of navitoclax via mTORC2 inhibition-mediated apoptotic signaling. Biochemical Pharmacology 200, pages 115045.
Crossref
Tianyuan Ci, Wentao Zhang, Yingyu Qiao, Huangjuan Li, Jing Zang, Hongjun Li, Nianping Feng & Zhen Gu. (2022) Delivery strategies in treatments of leukemia. Chemical Society Reviews 51:6, pages 2121-2144.
Crossref
Samiksha Wasnik. 2022. Combination Drug Delivery Approach as an Effective Therapy for Various Diseases. Combination Drug Delivery Approach as an Effective Therapy for Various Diseases 331 352 .
Jorge Gonzalez-Rico, Emanuel Nunez-Sardinha, Leticia Valencia, Angel Arias, Arrate Muñoz-Barrutia, Diego Velasco & Daniel Garcia-Gonzalez. (2021) Tuning the Cell and Biological Tissue Environment through Magneto-Active Materials. Applied Sciences 11:18, pages 8746.
Crossref
Mahesh P. More, Sagar R. Pardeshi, Chandrakantsing V. Pardeshi, Gaurav A. Sonawane, Mahesh N. Shinde, Prashant K. Deshmukh, Jitendra B. Naik & Abhijeet D. Kulkarni. (2021) Recent advances in phytochemical-based Nano-formulation for drug-resistant Cancer. Medicine in Drug Discovery 10, pages 100082.
Crossref
S. Pshenichnikov, A. Omelyanchik, M. Efremova, M. Lunova, N. Gazatova, V. Malashchenko, O. Khaziakhmatova, L. Litvinova, N. Perov, L. Panina, D. Peddis, O. Lunov, V. Rodionova & K. Levada. (2021) Control of oxidative stress in Jurkat cells as a model of leukemia treatment. Journal of Magnetism and Magnetic Materials 523, pages 167623.
Crossref
Maha M. Eissa, Mervat Z. El-Azzouni, Labiba K. El-Khordagui, Amany Abdel Bary, Riham M. El-Moslemany & Sara A. Abdel Salam. (2020) Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni. Parasites & Vectors 13:1.
Crossref
Yang Song, Xiangfu Guo, Jijun Fu, Bing He, Xueqing Wang, Wenbing Dai, Hua Zhang & Qiang Zhang. (2020) Dual-targeting nanovesicles enhance specificity to dynamic tumor cells in vitro and in vivo via manipulation of αvβ3-ligand binding. Acta Pharmaceutica Sinica B 10:11, pages 2183-2197.
Crossref
Ke Wang, Pu Wang, Menglong Wang, Deng-Guang Yu, Fuxian Wan & S.W. Annie Bligh. (2020) Comparative study of electrospun crystal-based and composite-based drug nano depots. Materials Science and Engineering: C 113, pages 110988.
Crossref
Kangjia Luo, Yanni Song, Zilong Guan, Hufei Wang, Jinhua Ye, Songlin Ran, Suwen Ou, Yangbao Tao, Zijian Gong, Tianyi Ma, Yinghu Jin, Rui Huang, Feng Gao & Shan Yu. (2022) A KRAS-Associated Signature for Prognostic Prediction in Colon Cancer. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.